Navigation Links
Liver Transplant Program Established At Montefiore
Date:8/20/2008

Area Residents Gain Access to High Quality Care as State Approves Only Program in The Bronx

NEW YORK, Aug. 20 /PRNewswire-USNewswire/ -- Patients who suffer from severe liver disease and need a liver transplant will no longer have to seek that highly specialized surgery and critically important follow-up care outside the borough of the Bronx. Area patients and their families now have access to this high-quality care locally, without having to travel long distances, as a result of the New York State Department of Health's approval of the first and only liver transplant program in the Bronx, at Montefiore Medical Center (http://www.montefiore.org).

"The liver transplantation program at Montefiore Medical Center fills a significant, unmet medical need for people who live in the Bronx and suffer from end-stage liver disease," said Steven M. Safyer, M.D., president and CEO of Montefiore.

"The Bronx has one of the highest rates of liver disease in the country and the highest rate of liver disease in New York State," said Dr. Safyer. "Until now, patients in the Bronx and surrounding areas who had liver disease had to travel outside of the borough to receive care, which was an additional burden on them and their families.

"Our liver transplant program now allows these patients to receive be cared for locally closer to home, by a team of professionals, at a center with an incredible amount of experience and expertise in all aspects of liver care," said Dr. Safyer.

The liver transplant program is part of the Montefiore-Einstein Liver Center and is supported by a research component from Albert Einstein College of Medicine's National Institutes of Health-funded Liver Center.

"We have a world class team of surgeons and liver specialists with a wide range of experience in treating and researching severe liver disease," said Milan Kinkhabwala, M.D., chief of transplantation and director of abdominal organ transplantation at Montefiore. "More than 120 Bronx patients were waiting for liver transplants in 2007, and approximately 50 local residents had no choice but to seek a liver transplant outside the borough last year," said Dr. Kinkhabwala.

While there are more than 2,300 people statewide currently waiting for a liver transplant, statistics for New York State show that risk factors for liver disease are significantly higher for residents of the Bronx when compared to other areas of the state.

Doctors at Montefiore believe there is actually 10 times the recorded number of people in the Bronx with serious liver problems. Montefiore's unique capabilities as an academic medical center help address these problems through community-based outreach, patient and physician education and the patient care provided by a nationally recognized team of liver specialists. Thousands of patients suffering from serious liver diseases including Hepatitis C, cirrhosis and cancer are treated annually at Montefiore.

"We have found there is a greater rate of alcohol use, intravenous drug use and confounding variables like malnutrition and diminished access to health care here in the Bronx," said Paul Gaglio, M.D., a nationally known liver expert and medical director of Montefiore's Liver Transplant Program. "The number of hospitalizations for liver-related diagnoses in Bronx-area hospitals has increased substantially, magnifying the importance of having an easily accessible local liver transplant center in the Bronx," said Dr Gaglio.

In addition to liver transplantation, Montefiore has programs in adult and pediatric heart transplantation, adult and pediatric kidney transplantation and bone marrow transplantation.

Montefiore Medical Center encompasses 124 years of outstanding patient care, innovative medical "firsts," pioneering clinical research, dedicated community service and ground-breaking social activism. A full-service, integrated delivery system caring for patients in the New York metropolitan region and beyond, Montefiore is a 1,491-bed medical center that includes: four hospitals -- the Henry and Lucy Moses Division, the Jack D. Weiler Division, the North Division and The Children's Hospital at Montefiore; a large home healthcare agency; the largest school health program in the U.S.; a 21-site medical group practice integrated throughout the Bronx and Westchester; and, a care management organization providing services to 179,000 health plan members.

In 2008, The Children's Hospital at Montefiore (http://www.montekids.org) ranks as one of "America's Best Children's Hospitals" in US News & World Report's prestigious annual listing. Montefiore is ranked by the Leapfrog Group among the top one percent of all U.S. hospitals based on its strategic investments in sophisticated and integrated healthcare technology.

Montefiore is committed to meeting the healthcare needs of the future through medical education and manages one of the largest residency programs in the country. Montefiore is The University Hospital and Academic Medical Center for Albert Einstein College of Medicine and has an affiliation with New York Medical College for residency programs at the North Division.

Distinguished centers of excellence at Montefiore include cardiology and cardiac surgery, cancer care, tissue and organ transplantation, children's health, women's health, surgery and the surgical subspecialties. Montefiore is a national leader in the research and treatment of diabetes, headaches, obesity, cough and sleep disorders, geriatrics and geriatric psychiatry, neurology and neurosurgery, adolescent and family medicine, HIV/AIDS and social and environmental medicine, among many other specialties. For more information, please visit http://www.montefiore.org or http://www.montekids.org.


'/>"/>
SOURCE Montefiore Medical Center
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Advanced Age No Bar to Liver Transplant
2. Researchers Find Better Way to Deliver Blood Thinner
3. Federal research plan to determine nanotech risks fails to deliver
4. Liver cancer marker could yield blood test for early detection
5. Blood Marker Might Help Spot Early Liver Cancer
6. Natural Protein Could Help Spot, Treat Liver Cancer
7. Diet Change Can Curb Fatty Liver Disease
8. US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer
9. The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer
10. Re-plumbing liver helps beat cancer
11. Free Prescription Drug Program Uses Internet to Deliver Cards - Offers Assistance to Uninsured
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... Pa. (PRWEB) , ... December 08, 2016 , ... ... Medicine Southern Chester County, a Property owned by an affiliate of Seavest, has ... square foot Penn Medicine Southern Chester County ambulatory care center (ACC) was named ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... access for customers and employees that are both engaging and easy to use. ... Smart Technology, the software company revealed today its plans to roll out new ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... has been recognized for adherence to the highest standards of trauma, maternity, ... organizations, announced the center's president and CEO, Dr. Daniel Messina. , Among the ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016   Hudes Laser ... December featuring the multi-wavelength Astanza Trinity laser and ... specializes in laser tattoo removal, IPL hair removal, ... ultrasound therapy. Hudes Laser Aesthetica is setting high ... and promises to deliver effective, long-lasting ...
(Date:12/9/2016)... OSAKA, Japan , Dec. 9, 2016 ... ; President & Representative Director, CEO: Dr. ... with amyotrophic lateral sclerosis (ALS) given edaravone intravenously in ... functional loss as measured by the ALS Functional Rating ... th International Symposium on ALS/MND in ...
(Date:12/9/2016)... 9, 2016  Axovant Sciences Ltd. (NYSE: ... focused on the treatment of dementia, today announced ... Phase 2b trial evaluating treatment with intepirdine (RVT-101), ... donepezil plus placebo in people with mild-to-moderate Alzheimer,s ... intepirdine to treatment was associated with reduced progression ...
Breaking Medicine Technology: